Early Diagnosis and Screening for Lung Cancer.

Area of Science:

• Oncology
• Molecular Biology
• Pulmonary Medicine

Background:

• Cancer interception strategies focus on preventing premalignant lesions from progressing to invasive cancer.
• Effective lung cancer interception is hindered by limited understanding of early molecular events, lack of preclinical models for pulmonary premalignancy, and challenges in early detection methods.

Purpose of the Study:

• This review summarizes current knowledge on molecular abnormalities in lung cancer progression.
• It also covers preclinical human models of lung cancer pathogenesis and recent advances in early lung cancer diagnostics.

Main Methods:

• Review of recent scientific literature on lung cancer interception.
• Analysis of advancements in next-generation sequencing and computational methodologies.
• Examination of progress in precision medicine and immuno-oncology relevant to cancer interception.

Main Results:

• Identified key molecular events in lung carcinogenesis.
• Highlighted the utility of novel preclinical models for studying pulmonary premalignancy.
• Summarized the progress in developing sensitive and specific diagnostic tools for early lung cancer detection.

Conclusions:

• Continued research into molecular events and improved preclinical models are crucial for effective lung cancer interception.
• Advancements in diagnostics, precision medicine, and immuno-oncology offer promising avenues for blocking lung cancer development.
• This review provides a comprehensive overview to guide future research and clinical strategies in lung cancer interception.